Cargando…
MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response
The p53 inhibitor, MDM4 (MDMX) is a cytoplasmic protein with p53-activating function under DNA damage conditions. Particularly, MDM4 promotes phosphorylation of p53 at Ser46, a modification that precedes different p53 activities. We investigated the mechanism by which MDM4 promotes this p53 modifica...
Autores principales: | Mancini, F, Pieroni, L, Monteleone, V, Lucà, R, Fici, L, Luca, E, Urbani, A, Xiong, S, Soddu, S, Masetti, R, Lozano, G, Pontecorvi, A, Moretti, F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717155/ https://www.ncbi.nlm.nih.gov/pubmed/25961923 http://dx.doi.org/10.1038/onc.2015.76 |
Ejemplares similares
-
MDM4 actively restrains cytoplasmic mTORC1 by sensing nutrient availability
por: Mancini, Francesca, et al.
Publicado: (2017) -
Inhibition of the mTOR pathway and reprogramming of protein synthesis by MDM4 reduce ovarian cancer metastatic properties
por: Lucà, Rossella, et al.
Publicado: (2021) -
Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4
por: Lucà, Rossella, et al.
Publicado: (2019) -
HIPK2 sustains apoptotic response by phosphorylating Che-1/AATF and promoting its degradation
por: De Nicola, F, et al.
Publicado: (2014) -
HIPK2-T566 autophosphorylation diversely contributes to UV- and doxorubicin-induced HIPK2 activation
por: Verdina, Alessandra, et al.
Publicado: (2017)